等待开盘 02-06 09:30:00 美东时间
0.000
0.00%
TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has successfully completed t...
2023-07-12 07:00
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as patents for some of the industry's blockbuster drugs are on the expiration cliff.
2023-07-08 01:18
转自:药融圈 眼科并购合作 Iveric Bio专注于眼科领域新疗法的研发。Iveric Bio于2023年2月宣布,美国食品和药品管理局(FDA)接受了Av...
2023-06-16 08:04
NEW YORK, May 9, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or b...
2023-05-10 00:18
NEW YORK, May 1, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IVERIC bio, Inc. ("IVERIC" or th...
2023-05-02 11:04
NEW YORK, May 1, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or b...
2023-05-02 05:22
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Apollomics, Inc. (NASDAQ: APLM) surged 58.4% to $7.35 in pre-market trading after declining around 3% on Friday.
2023-05-01 19:32
Guggenheim analyst Eddie Hickman downgrades IVERIC bio (NASDAQ:ISEE) from Buy to Neutral.
2023-05-01 19:06
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and IVERIC Bio, Inc. (NASDAQ: ISEE, CEO: Glenn P.
2023-05-01 07:15
IVERIC bio, Inc. (NASDAQ:ISEE – Get Rating) CFO David Francis Carroll sold 48,1...
2023-04-26 08:33